These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 21091952)

  • 21. Modifiable vascular markers for cognitive decline and dementia: the importance of arterial aging and hemodynamic factors.
    Pase MP
    J Alzheimers Dis; 2012; 32(3):653-63. PubMed ID: 22810095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.
    Walters MJ; Sterling J; Quinn C; Ganzer C; Osorio RS; Andrews RD; Matthews DC; Vallabhajosula S; de Leon MJ; Isaacson RS; Mosconi L
    BMJ Open; 2018 Nov; 8(11):e023664. PubMed ID: 30478117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of cerebrovascular aging on vascular cognitive impairment and dementia.
    Yang T; Sun Y; Lu Z; Leak RK; Zhang F
    Ageing Res Rev; 2017 Mar; 34():15-29. PubMed ID: 27693240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorting out the clinical consequences of ischemic lesions in brain aging: a clinicopathological approach.
    Gold G; Kovari E; Hof PR; Bouras C; Giannakopoulos P
    J Neurol Sci; 2007 Jun; 257(1-2):17-22. PubMed ID: 17321551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors.
    Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ;
    Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension and cognitive function in the elderly.
    Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
    Am J Ther; 2007; 14(6):533-54. PubMed ID: 18090879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons.
    Kapasi A; Schneider JA
    Biochim Biophys Acta; 2016 May; 1862(5):878-86. PubMed ID: 26769363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk factors and dementia.
    Fillit H; Nash DT; Rundek T; Zuckerman A
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):100-18. PubMed ID: 18675769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.
    Payami H; Grimslid H; Oken B; Camicioli R; Sexton G; Dame A; Howieson D; Kaye J
    Am J Hum Genet; 1997 Apr; 60(4):948-56. PubMed ID: 9106542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes and the brain: issues and unmet needs.
    Bornstein NM; Brainin M; Guekht A; Skoog I; Korczyn AD
    Neurol Sci; 2014 Jul; 35(7):995-1001. PubMed ID: 24777546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dementia, quantitative neuroimaging, and apolipoprotein E genotype.
    Bigler ED; Lowry CM; Anderson CV; Johnson SC; Terry J; Steed M
    AJNR Am J Neuroradiol; 2000; 21(10):1857-68. PubMed ID: 11110538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
    Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
    JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney function is associated with the rate of cognitive decline in the elderly.
    Buchman AS; Tanne D; Boyle PA; Shah RC; Leurgans SE; Bennett DA
    Neurology; 2009 Sep; 73(12):920-7. PubMed ID: 19657107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular risk factors: imaging and neuropathologic correlates.
    Knopman DS; Roberts R
    J Alzheimers Dis; 2010; 20(3):699-709. PubMed ID: 20182020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function.
    Bischof GN; Park DC
    Psychosom Med; 2015; 77(6):697-709. PubMed ID: 26107577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
    Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
    BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.